Posts in Category: stocks

The (Drug) Price Is (Sort Of) Right! (Sometimes)

Spending the day, as I often do, listening to company conference presentations and/or–in today’s case, and–meetings with management teams.  Today, I’m in drug world (no, not the way you might think).

So what’cha got?  Some interesting sidelights on drug pricing from a conference presentation this morning, given by a company, Neurocrine

Read More